Results 131 to 140 of about 39,174 (210)

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice [PDF]

open access: yes, 2017
Esser, Alison K   +11 more
core   +2 more sources

HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population

open access: yesRevista de Saúde Pública
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was performed to estimate the prevalence of HTLV-I/II infection in a low risk population and to better understand determinants associated with seropositivity.
Bernadette Catalan Soares   +2 more
doaj  

Molecular diagnosis of HTLV-1 and HCV infection in polytransfused sickle cell disease in Kinshas: case of CMMASS. [PDF]

open access: yesBMC Infect Dis
Ilunga AKK   +10 more
europepmc   +1 more source

Cytotoxic Effects of a Triorganotin Derivative on HTLV-1-Infected Cells at Different Immortalization/Transformation Stages In Vitro. [PDF]

open access: yesMolecules
Stefanizzi V   +11 more
europepmc   +1 more source

ANTI-HTLV-I p19 SUPPRESSES HTLV-I AG EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES FROM HTLV-I CARRJERS

open access: yesANTI-HTLV-I p19 SUPPRESSES HTLV-I AG EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES FROM HTLV-I CARRJERS
Anti-HTLV-I antibodies possess an inhibitory action for HTLV-I infection. In cases where cells persistently expressing HTLV-I antigen are the source of infection m an in vitro system, antibodies against HTLV-I env antigens (such as anti-HTLV-I gp46 175-199 antibody, etc.) have an inhibitory action for HTLV-I cell to cell infection.
openaire  

Home - About - Disclaimer - Privacy